凝血因子Ⅴ(F5)重組蛋白
Recombinant Coagulation Factor V (F5)
FV; FVL; PCCF; Proaccelerin; Labile Factor; Factor V Leiden; Accelerator Globulin; Activated protein C cofactor; Proaccelerin, labile factor
- 編號(hào)RPA675Ra01
 - 物種Rattus norvegicus (Rat,大鼠)相同的名稱(chēng),不同的物種。
 - 來(lái)源原核表達(dá)
 - 宿主E.coli
 - 內(nèi)毒素水平<1.0EU/µg(LAL法測(cè)定)
 - 亞細(xì)胞定位高爾基體, 內(nèi)質(zhì)網(wǎng)腔, 細(xì)胞外基質(zhì)
 - 預(yù)測(cè)分子量21.7kDa
 - 實(shí)際分子量20kDa(差異分析請(qǐng)參閱說(shuō)明書(shū))
 - 片段與標(biāo)簽Cys1944~Cys2099 with N-terminal His Tag
 - 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
 - 性狀凍干粉
 - 純度> 90%
 - 等電點(diǎn)10
 - 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請(qǐng)參見(jiàn)活性蛋白。 - 下載英文說(shuō)明書(shū) 中文說(shuō)明書(shū)
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價(jià)格¥ 840¥ 2100¥ 4200¥ 12600¥ 31500
 - 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷(xiāo)商聯(lián)系!
 
序列

用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲(chǔ)存
避免反復(fù)凍融。2-8°C不超過(guò)一個(gè)月,-80°C不超過(guò)12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒(méi)有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPA675Ra01 | 凝血因子Ⅴ(F5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA675Ra01 | 凝血因子Ⅴ(F5)多克隆抗體 | WB; IHC; ICC; IP. | 
| MAA675Ra21 | 凝血因子Ⅴ(F5)單克隆抗體 | WB; IHC; ICC; IP. | 
| SEA675Ra | 凝血因子Ⅴ(F5)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMA675Ra | 凝血因子Ⅴ(F5)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| Biochem Biophys Res Commun | Thrombin generation in abdominal sepsis is Rho-kinase-dependent[PubMed: 25813486] | 
| Cell Transplantation | Evidence of a Pivotal Role for the Distal Part of the Complement Cascade in the Diurnal Release of Hematopoietic Stem Cells Into Peripheral Blood[Pubmed:26087465] | 
| Cardiovascular?Research | Loss of accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity[Pubmed:29444200] | 



